The 'green rush' is on for marijuana companies
Changes in state pot laws are encouraging some cannabis-related companies to go public.
By Bruce
Kennedy Wed 3:02 PM
These
are heady times for supporters of legalized marijuana as well as those looking
to cash in on pot's growing national acceptance. This month, voters in
Washington state and Colorado agreed to legalize the recreational use of
marijuana for adults. And medical marijuana is currently legal in 18 states and
Washington D.C.
Of course, marijuana remains illegal by federal law. But people involved in what some are calling the "green rush" are still looking at business and investment opportunities in cannabis and its production.
And as with nearly all markets, some people are willing to take the risk.
Scott, a former federal regulatory attorney, estimates there are about 10 cannabis-related companies currently being traded as over-the-counter stocks. Most OTCs are relatively small and often new companies that don't yet meet the requirements to be listed or traded on exchanges like Nasdaq or the New York Stock Exchange.
He breaks down these marijuana sector firms into four groups:
So are these small stocks worth an investor's time? It depends on how the future plays out for the sector.
"If the new marijuana laws in Colorado and Washington… are a sign of things to come, if you're a firm that can benefit by this industry being created into a legal and viable industry, then if you can get in early enough, then those stocks may go up in value," says Mac Clouse, professor of finance at the University of Denver's Daniels College of Business.
Of course, marijuana remains illegal by federal law. But people involved in what some are calling the "green rush" are still looking at business and investment opportunities in cannabis and its production.
And as with nearly all markets, some people are willing to take the risk.
"Think of it as another dot.com explosion," said
Bruce Perlowin, CEO of Hemp Inc. (HEMP
-1.61%), in a recent press
release.
And according to an investor
fact sheet for Medical Marijuana Inc. (MJNA
-0.85%), the current U.S. medical marijuana industry is estimated at $17
billion, with expectations it could grow up to about $29 billion by 2016.
"It was almost unthinkable 10 years ago that you
would have legitimate, fully reporting to the SEC companies that were in the
nature of pure plays, with positions in the medical marijuana industry," says
Sterling Scott, CEO of Los Angeles-based GrowLife Inc. (PHOT
-9.52%), a consortium of companies that sells products for indoor growing.
Scott, a former federal regulatory attorney, estimates there are about 10 cannabis-related companies currently being traded as over-the-counter stocks. Most OTCs are relatively small and often new companies that don't yet meet the requirements to be listed or traded on exchanges like Nasdaq or the New York Stock Exchange.
He breaks down these marijuana sector firms into four groups:
- Established companies, like GrowLife, that sell equipment and expendables for the cannabis industry.
- Companies like Medical Marijuana, whose mission, according to its website, is to become the industry's "premier cannabis and hemp industry innovators."
- Groups like Hemp Inc. that are looking to develop a legal market for the industrial and commercial use of hemp (which contains only trace amounts of marijuana's active ingredient) in products such as paper, oils and cloth.
- Companies focused on the clinical, medical use of cannabis in areas such as cancer, inflammation and pain treatment.
So are these small stocks worth an investor's time? It depends on how the future plays out for the sector.
"If the new marijuana laws in Colorado and Washington… are a sign of things to come, if you're a firm that can benefit by this industry being created into a legal and viable industry, then if you can get in early enough, then those stocks may go up in value," says Mac Clouse, professor of finance at the University of Denver's Daniels College of Business.
No comments:
Post a Comment